Latest filing published 26 Aug 2025 for OrganoClick AB, €778.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Sten Åkerblom in OrganoClick AB, where the filings describe the role as board member. The record holds 15 filings, for trades running from 22 December 2021 to 9 December 2025.
Both buying and selling appear: 14 purchases worth €58k, against 1 sale worth €7,638. Purchases outweigh sales by €51k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 7 purchases and 1 sale on the market.
In size, the median ticket on the buying side is €811. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 11 December 2025: an open-market sale of €7,638, in OrganoClick AB. The most recent open-market purchase was published on 26 August 2025, 424 days ago. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations